NOVONORM

This brand name is authorized in Austria, Cyprus, Estonia, Spain, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, Poland, Singapore, Tunisia

Active ingredients

The drug NOVONORM contains one active pharmaceutical ingredient (API):

1 Repaglinide UNII 668Z8C33LU - REPAGLINIDE

Repaglinide is a short-acting oral secretagogue. Repaglinide lowers the blood glucose levels acutely by stimulating the release of insulin from the pancreas, an effect dependent upon functioning β-cells in the pancreatic islets. Read about Repaglinide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BX02	Repaglinide	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BX Other blood glucose lowering drugs, excl. insulins
Discover more medicines within A10BX02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1039171, 1039182, 1044638, 1065204, 1065259, 1065260, 1214536, 1214558, 1214570, 1214581, 1214592, 1214604, 1304862, 1304873, 1304884
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 98076005, 98076012, 98076019
Country: FR	Base de données publique des médicaments	Identifier(s): 62522076, 63576333, 67364819
Country: HK	Department of Health Drug Office	Identifier(s): 44796, 44797, 44812
Country: IE	Health Products Regulatory Authority	Identifier(s): 76407, 76453, 76474, 76497
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3808, 3809, 3810
Country: IT	Agenzia del Farmaco	Identifier(s): 034162053, 034162127, 034162192, 042114013, 042114025, 043987015, 044421016, 044421028
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1004266, 1004267, 1004268, 1006525, 1008354, 1008355, 1029889, 1029891, 1029892, 1029894, 1029895, 1029897
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 50911, 50938, 50946
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100000652, 100082740, 100083715
Country: SG	Health Sciences Authority	Identifier(s): 10672P, 10673P, 10674P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5993061, 5993062, 5993063, 5993064, 5993065, 5993066